期刊档案
Encephalitis
ISSN 2765-4559 · eISSN 2734-1461 · Korean Encephalitis and Neuroinflammation Society · Korea, Republic of
Encephalitis 钻石开放获取（无 APC），免版面费，近 24 个月 28 篇文章投稿到接收中位 64 天，2025 年发文 14 篇。
研究范围
研究范围与定位
Encephalitis 由 Korean Encephalitis and Neuroinflammation Society 出版。按 OpenAlex 近年发文统计，该刊主要发表 Infectious Encephalopathies and Encephalitis、Autoimmune Neurological Disorders and Treatments、Peripheral Neuropathies and Disorders 等主题的论文，这 3 个主题约占 43.8%，主导子领域为 Neurology。（根据 OpenAlex 主题统计与中科院分区数据生成）
encephalitis is a peer-reviewed, Open Access journal that publishes original research articles, review/mini-review articles, and experimental or clinical studies/case reports on encephalitis and neuroinflammation. The journal was launched in January 2021 and is published quarterly on the 10th of every January, April, July, and October. Encephalitis is a disease caused by the neuroinflammation in the brain. Neuroinflammation refers to inflammation that occurs in the nerves system. It can be triggered by a variety of causes or events, including infection, traumatic brain injury, seizure, toxic metabolites, and autoimmune responses. Acute inflammation is characterized by transient changes in inflammatory molecules, endothelial cell activation, and platelet deposition, but chronic inflammation is involved in the prolonged activation of glial cells and recruitment of other immune cells into the brain. The symptoms of encephalitis include severe headache, fever, confusion, seizures, trouble speaking, and memory problems. Although viral infections are considered the most common cause of encephalitis, in many cases the cause remains unknown, although it can be life-threatening. It is important to get a timely diagnosis and treatment. Priority of encephalitis is given to work that provides translational and/or fundamental insight into the workings of encephalitis and neuro-immune interactions in the brain. covers a wide range of topics related to encephalitis/neuroinflammation including neuroscience, immunology, pathophysiology, pharmacology, microbiology, genomics, diagnosis, cure of infectious diseases, and related general experimental and clinical research on the nervous system. encephalitis serves as the major conduit of top-quality information for neuroscientist or neurobiologist community, as well as the neurologist community. Acceptance for publication of submitted manuscript is determined by the editors and peer reviewers, who are experts in their specific fields of each topic. Review processing is performed by the editorial board members of journal and outside experts. All published articles will be assigned DOI provided by CrossRef.
摘自期刊官网 Aims & Scope
主编 Kyung-Il Park出版商官网
编委会国家分布：未见中国大陆编委；主要国家 韩国 17、日本 1、印度 1（共 19 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Infectious Encephalopathies and EncephalitisMedicine21%
- Autoimmune Neurological Disorders and TreatmentsMedicine14.7%
- Peripheral Neuropathies and DisordersMedicine8%
- Epilepsy research and treatmentMedicine6.7%
- Bacterial Infections and VaccinesImmunology and Microbiology6.3%
- Multiple Sclerosis Research StudiesMedicine4%
- Herpesvirus Infections and TreatmentsMedicine3.6%
- Long-Term Effects of COVID-19Medicine3.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 9OpenAlex ·
- i10-index
- 9OpenAlex ·
- 两年平均被引
- 1.52OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 113 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 20 | 20 | 113 |
| 2025 | 14 | 14 | 100 |
| 2024 | 16 | 16 | 79 |
| 2023 | 21 | 21 | 17 |
| 2022 | 12 | 12 | 11 |
| 2021 | 22 | 22 | 2 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
64 天投稿到接收中位数 · P25–P75 54 天 – 118 天
- 接收到上线
- 中位数 72 天（28 篇）
- 投稿到上线
- 中位数 176 天
- 样本
- 28 篇有投稿与接收日期的文章（窗口内共 35 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 15 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 15 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY-NC | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 有，金额未公布 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点3 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 3–5 个
- 推荐审稿人
- 可选
接收的文章类型11 种，含篇幅限制
- case reports, tables, figure legends, and figures. Case reports are limited to 2,000 words (excluding the abstract, references, tables, and legends),正文 ≤ 2,000 词
- clinical studies/case reportspublishing original research articles, review/mini-review articles, and clinical studies/case reports, perspectives, and letters to the editor未说明篇幅
- editorialbe of interest to encephalitis readers. Editorials should not exceed 1,000 words, excluding references, tables, and figures. References shou正文 ≤ 1,000 词
- letterreply. No abstraction is required. The letter should be 1,000 words or less (excluding references and figure legends) with a ma正文 ≤ 1,000 词
- letters to the editorpublishing original research articles, review/mini-review articles, and clinical studies/case reports, perspectives, and letters to the editor未说明篇幅
- original articleOriginal Article未说明篇幅
- original research articlespublishing original research articles, review/mini-review articles, and clinical studies/case reports, perspectives, and letters to the editor未说明篇幅
- perspectivespublishing original research articles, review/mini-review articles, and clinical studies/case reports, perspectives, and letters to the editor未说明篇幅
- review• The submitted manuscript will first be evaluated at the editorial office regarding the completeness of the submitted materials and their suitability to enceph…未说明篇幅
- review articleReview Article未说明篇幅
- review/mini-review articlespublishing original research articles, review/mini-review articles, and clinical studies/case reports, perspectives, and letters to the editor未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、预印本
- AI 使用 Use of artificial intelligence (AI)-assisted technologies
该期刊采用ICMJE关于AI使用的政策：生成式AI可用于提升科学写作的可读性与语言准确性，但AI不能列为作者，且不允许用生成式AI创建或修改投稿稿件中的图像。 模型中文摘要
The journal has adopted policies, as specified by the ICMJE, regarding the use of AI in the preparation of materials intended for publication in the journal. Generative AI, including language models, chatbots, image creators, machine learning, and similar technologies, can be employed to enhance readability and language accuracy in scientific writing. However, chatbots or other AI-assisted technol…
原文 ↗出版商官网 ·- 作者资格 Authorship and Author’s Responsibility
通讯作者在投稿、同行评审和发表过程中承担与期刊沟通的主要责任，并通常负责确保作者身份、伦理审批、临床试验注册文件及利益冲突表等行政要求得到妥善完成。 模型中文摘要
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statement…
原文 ↗出版商官网 ·- 利益冲突 Conflict of Interest
作者应披露所有潜在利益冲突，包括研究经费、其他财务支持和物质支持；通讯作者必须告知编辑任何可能影响数据解读的潜在利益冲突。 模型中文摘要
The authors should disclose all potential conflicts of interest including any research funding, other financial support, and material support for the work. The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. If there is a disclosure, the editors, reviewers, and reader can approach the manuscripts after…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing Statement
该期刊接受ICMJE关于数据共享声明的建议政策，作者可参考相关社论。 模型中文摘要
encephalitis accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). Authors may refer to the editorial, "Data Sharing statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors," in JKMS vol. 32, no. 7:1051-1053 (https://doi.org/10.3346/jkms.2017.32.7.1051).
原文 ↗出版商官网 ·- 许可与版权
所有已发表材料的版权归韩国脑炎与神经炎症学会所有，作者投稿时必须签署版权转让协议。 模型中文摘要
Copyrights of all published materials are owned by the Korean Society of Encephalitis and Neuroinflammation. All authors must sign the Transfer of Copyright Agreement when they submit their manuscript.
原文 ↗出版商官网 ·- 开放获取 COPYRIGHTS, OPEN ACCESS, OPEN DATA, ARCHIVING, AND DEPOSIT POLICY
该期刊为开放获取期刊，采用知识共享署名-非商业性使用许可（CC BY-NC 4.0），允许在注明出处的前提下进行非商业性使用、分发和复制。 模型中文摘要
Copyrights The manuscript, when published, will become the property of the journal. Copyrights of all published materials are owned by the Korean Society of Encephalitis and Neuroinflammation. All authors must sign the Transfer of Copyright Agreement when they submit their manuscript. Copyright transfer agreement form (https://www.encephalitisjournal.org/authors/copyright_transfer_agreement.php). …
原文 ↗出版商官网 ·- 同行评审 REVIEW PROCESS AND MANUSCRIPT DECISION
投稿稿件先由编辑部评估材料完整性与适配性，随后通常由编辑及两名相关领域同行评审专家进行评审；作者可建议偏好或不偏好的审稿人，但最终由编辑决定。 模型中文摘要
• The submitted manuscript will first be evaluated at the editorial office regarding the completeness of the submitted materials and their suitability to encephalitis. Modifications/corrections may be requested from the authors at this stage before starting the peer review. • Submitted manuscripts will generally be reviewed by the editors, as well as two peer reviewers who are experts in the submi…
原文 ↗出版商官网 ·- 预印本
该期刊接受曾以预印本形式出现的稿件投稿，前提是稿件未同时在其他期刊审稿中。 模型中文摘要
encephalitis accepts submissions of manuscripts that have previously appeared as preprints, provided they are not simultaneously under review at another journal.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Korean Encephalitis and Neuroinflammation Society
- 出版国家或地区
- Korea, Republic of
- 出版语言
- English
- ISSN
- 2765-4559
- 电子版 ISSN
- 2734-1461
- 官网最新一期
- Volume 6（2026 年 7 月）
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 Encephalitis 的常见问题
Encephalitis 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）28 篇已发表文章登记的日期，投稿到接收的中位数为 64 天（四分位 54–118 天）；投稿社区反馈的平均审稿速度为约 15 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Encephalitis 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：3–5 个；推荐审稿人：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Encephalitis 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 19 位编委中，没有中国大陆学者；人数最多的国家是 韩国（17 位）、日本（1 位）、印度（1 位）。统计按编委会页面列出的机构国家计，仅供参考。
Encephalitis 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Encephalitis 被 DOAJ 收录。
Encephalitis 是开放获取期刊吗？版面费多少？
Encephalitis 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。